Cargando…
COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess COVID-19 booster dose vaccination coverage am...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796208/ https://www.ncbi.nlm.nih.gov/pubmed/36480674 http://dx.doi.org/10.3201/eid2901.221151 |
_version_ | 1784860430852685824 |
---|---|
author | Lu, Peng-jun Srivastav, Anup Vashist, Kushagra Black, Carla L. Kriss, Jennifer L. Hung, Mei-Chuan Meng, Lu Zhou, Tianyi Yankey, David Masters, Nina B. Fast, Hannah E. Razzaghi, Hilda Singleton, James A. |
author_facet | Lu, Peng-jun Srivastav, Anup Vashist, Kushagra Black, Carla L. Kriss, Jennifer L. Hung, Mei-Chuan Meng, Lu Zhou, Tianyi Yankey, David Masters, Nina B. Fast, Hannah E. Razzaghi, Hilda Singleton, James A. |
author_sort | Lu, Peng-jun |
collection | PubMed |
description | The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess COVID-19 booster dose vaccination coverage among adults. We used multivariable logistic regression analysis to assess factors associated with vaccination. COVID-19 booster dose coverage among fully vaccinated adults increased from 25.7% in November 2021 to 63.4% in March 2022. Coverage was lower among non-Hispanic Black (52.7%), and Hispanic (55.5%) than non-Hispanic White adults (67.7%). Coverage was 67.4% among essential healthcare personnel, 62.2% among adults who had a disability, and 69.9% among adults who had medical conditions. Booster dose coverage was not optimal, and disparities by race/ethnicity and other factors are apparent in coverage uptake. Tailored strategies are needed to educate the public and reduce disparities in COVID-19 vaccination coverage. |
format | Online Article Text |
id | pubmed-9796208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-97962082023-01-09 COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 Lu, Peng-jun Srivastav, Anup Vashist, Kushagra Black, Carla L. Kriss, Jennifer L. Hung, Mei-Chuan Meng, Lu Zhou, Tianyi Yankey, David Masters, Nina B. Fast, Hannah E. Razzaghi, Hilda Singleton, James A. Emerg Infect Dis Research The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess COVID-19 booster dose vaccination coverage among adults. We used multivariable logistic regression analysis to assess factors associated with vaccination. COVID-19 booster dose coverage among fully vaccinated adults increased from 25.7% in November 2021 to 63.4% in March 2022. Coverage was lower among non-Hispanic Black (52.7%), and Hispanic (55.5%) than non-Hispanic White adults (67.7%). Coverage was 67.4% among essential healthcare personnel, 62.2% among adults who had a disability, and 69.9% among adults who had medical conditions. Booster dose coverage was not optimal, and disparities by race/ethnicity and other factors are apparent in coverage uptake. Tailored strategies are needed to educate the public and reduce disparities in COVID-19 vaccination coverage. Centers for Disease Control and Prevention 2023-01 /pmc/articles/PMC9796208/ /pubmed/36480674 http://dx.doi.org/10.3201/eid2901.221151 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Lu, Peng-jun Srivastav, Anup Vashist, Kushagra Black, Carla L. Kriss, Jennifer L. Hung, Mei-Chuan Meng, Lu Zhou, Tianyi Yankey, David Masters, Nina B. Fast, Hannah E. Razzaghi, Hilda Singleton, James A. COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 |
title | COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 |
title_full | COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 |
title_fullStr | COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 |
title_full_unstemmed | COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 |
title_short | COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 |
title_sort | covid-19 booster dose vaccination coverage and factors associated with booster vaccination among adults, united states, march 2022 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796208/ https://www.ncbi.nlm.nih.gov/pubmed/36480674 http://dx.doi.org/10.3201/eid2901.221151 |
work_keys_str_mv | AT lupengjun covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT srivastavanup covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT vashistkushagra covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT blackcarlal covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT krissjenniferl covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT hungmeichuan covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT menglu covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT zhoutianyi covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT yankeydavid covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT mastersninab covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT fasthannahe covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT razzaghihilda covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 AT singletonjamesa covid19boosterdosevaccinationcoverageandfactorsassociatedwithboostervaccinationamongadultsunitedstatesmarch2022 |